Combination of hmg-coa reductase inhibitors with...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/44 (2006.01) A61K 31/22 (2006.01) A61K 31/277 (2006.01) A61K 31/343 (2006.01) A61K 31/352 (2006.01) A61K 31/366 (2006.01) A61K 31/40 (2006.01) A61K 31/405 (2006.01) A61K 31/437 (2006.01) A61K 31/4439 (2006.01) A61K 31/453 (2006.01) A61K 31/502 (2006.01) A61K 31/505 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2656366

The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the preventive and curative treatment of an inflammatory pulmonary disease.

L'invention concerne l'utilisation combinée d'un inhibiteur de PDE4 et d'un inhibiteur de HMG-CoA réductase pour le traitement préventif et curatif d'une maladie pulmonaire inflammatoire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of hmg-coa reductase inhibitors with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of hmg-coa reductase inhibitors with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of hmg-coa reductase inhibitors with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1822965

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.